KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Operating Leases (2019 - 2025)

GoodRx Holdings' Operating Leases history spans 7 years, with the latest figure at $54.5 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 18.47% year-over-year to $54.5 million; the TTM value through Dec 2025 reached $54.5 million, up 18.47%, while the annual FY2025 figure was $54.5 million, 18.47% up from the prior year.
  • Operating Leases for Q4 2025 was $54.5 million at GoodRx Holdings, up from $51.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $56.3 million in Q1 2023 and bottomed at $32.0 million in Q3 2021.
  • The 5-year median for Operating Leases is $48.0 million (2023), against an average of $44.7 million.
  • The largest annual shift saw Operating Leases soared 73.1% in 2023 before it dropped 12.75% in 2025.
  • A 5-year view of Operating Leases shows it stood at $33.6 million in 2021, then surged by 61.14% to $54.1 million in 2022, then dropped by 10.58% to $48.4 million in 2023, then dropped by 4.88% to $46.0 million in 2024, then increased by 18.47% to $54.5 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Operating Leases are $54.5 million (Q4 2025), $51.3 million (Q3 2025), and $52.7 million (Q2 2025).